Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
» TGX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

TGX Guru Trades in Q1 2013

Jim Simons 1,588,000 sh (+1.51%)
Chuck Royce 202,377 sh (unchged)
» More
Q2 2013

TGX Guru Trades in Q2 2013

Jim Simons 1,618,300 sh (+1.91%)
Chuck Royce Sold Out
» More
Q3 2013

TGX Guru Trades in Q3 2013

Jim Simons 1,739,600 sh (+7.5%)
» More
Q4 2013

TGX Guru Trades in Q4 2013

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with TGX



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:THX.Germany
Theragenics Corporation is a Delaware Corporation formed in 1981. It is a medical device company serving the surgical products and cancer treatment markets, operate in two business segments; the surgical products segment and the brachytherapy seed segment. The Company's surgical products business manufactures markets and sells disposable devices utilized in certain surgical procedures. Its brachytherapy seed business manufactures markets and sells radioactive 'seeds' utilized in the treatment of early stage prostate cancer. Its surgical products business was built through the acquisitions of CP Medical Corp. in May 2005, Galt Medical Corporation in August 2006, and NeedleTech Products, Inc. in July 2008. The Company manufactures almost 3,500 products in this business as part of three broad product platforms; wound closure, vascular access and specialty needles. It serves a number of markets and applications, including, among other areas, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. With the exception of veterinary sutures, its surgical products hold relatively small market shares. Its products include both finished goods and components. The Company's products are sold mainly to original equipment manufacturers and to a network of distributors. The Company's facilities and operations are subject to extensive environmental, nuclear, regulatory and occupational health and safety laws at the federal, state and local levels. It is also subject to similar foreign laws and regulations under certain circumstances when its products are distributed outside of the United States.
» More Articles for TGX

Headlines

Articles On GuruFocus.com
Theragenics Corp. Reports Operating Results (10-K) Feb 25 2011 
Theragenics Corp. Reports Operating Results (10-Q) Aug 12 2010 
Theragenics Corp. Reports Operating Results (10-Q) May 14 2010 
Theragenics Corp. Reports Operating Results (10-Q) Nov 13 2009 
Theragenics Corp. Reports Operating Results (10-Q) Aug 13 2009 
Theragenics® Reports Revenue & Earnings for Second Quarter 2009 Aug 06 2009 
Theragenics Corporation® to Report Second Quarter 2009 Earnings Results Thursday, August 6, 2009 Jul 28 2009 
Theragenics Corp. Reports Operating Results (10-Q) May 12 2009 
Theragenics Corporation® Announces Schedule for Fourth Quarter and Year-End 2008 Conference Call Feb 09 2009 

More From Other Websites
Theragenics Announces Completion of Merger with Juniper Oct 29 2013
Theragenics completes merger with Juniper Investment Oct 29 2013
Theragenics Announces Completion of Merger with Juniper Oct 29 2013
THERAGENICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Oct 22 2013
Theragenics Announces Stockholder Approval of Merger Agreement with Juniper Oct 17 2013
THERAGENICS CORP Files SEC form 8-K, Other Events Oct 07 2013
Theragenics Announces Expiration of the “Go-Shop” Period and Sets Date for Stockholders Meeting... Sep 09 2013
New Survey Reveals Men Are at Odds with U.S. Preventive Services Task Force Recommendations Against... Aug 26 2013
THERAGENICS CORP Financials Aug 20 2013
THERAGENICS CORP Files SEC form 10-Q, Quarterly Report Aug 13 2013
THERAGENICS CORPORATION SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible... Aug 08 2013
THERAGENICS CORP Files SEC form 8-K, Results of Operations and Financial Condition Aug 08 2013
Theragenics Corporation Reports Second Quarter 2013 Results Aug 08 2013
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary... Aug 07 2013
THERAGENICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material... Aug 07 2013
Faruqi & Faruqi, LLP, Partner Juan E. Monteverde is Seeking More Cash for the Shareholders of... Aug 06 2013
Investor Alert: Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of... Aug 06 2013
Theragenics to Report Second Quarter 2013 Financial Results on August 8, 2013 Aug 06 2013
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary... Aug 05 2013
Theragenics accepts Juniper bid worth $2.20/share Aug 05 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide